COVID-19 Vaccine Could Turn Emotions All Of A Sudden

Since the U-turn seen by Pfizer’s vaccine for COVIE-19, while the fantasy of a COVID-free world propelled positive hopes for rapid economic recover; proved only a foul play with inflow of news that Pfizer (NYSE:PFE) CEO made $5.6 million stock sale on same day as COVID-19 vaccine update.

Once again, Pfizer going to announce crucial COVID-19 vaccine data as early as this week; could try to regenerate positive hopes among the investors. But, will it have the same impact over the emotions of the investors who believed Pfizer’s claim of 90% accuracy of its vaccine blindfolded? Especially, at the time while a plethora of queries on efficacy of the Pfizer’s vaccine still in the queue.

There is no doubt that more data from vaccine creator Moderna (NASDAQ:MRNA). is expected in the coming days, while AstraZeneca (NYSE:AZN) and its partner, the University of Oxford, may also have preliminary results in the next few weeks. Johnson & Johnson (NYSE:JNJ) has launched a new large-scale late-stage trial today to test a two-dose regimen of its experimental COVID-19 vaccine and evaluate potential incremental benefits for the duration of protection with a second dose.

Finally, I conclude that the Pfizer’s first move has resulted in extreme alertness among the investors to doubt every such claim in near futures; till its efficacy is not proved to eliminate COVID-19 completely for the earth. There is no doubt that the global equity markets have entered into an extremely overbought territory, even if a successful vaccine emerge; because the growing number of coronavirus infections has damaged the global economy up to a greater extent; which could rather take more time to resume normalcy.

 

Disclaimer

1. This content is for information and educational purposes only and should not be considered as investment advice or an investment recommendation. Past performance is not an indication of future results. All trading carries risk. Only risk capital be involved which you are prepared to lose.

2. Remember, YOU push the buy button and the sell button. Investors are always reminded that before making any investment, you should do your own proper due diligence on any name directly or indirectly mentioned in this article. Investors should also consider seeking advice from an investment and/or tax professional before making any investment decisions. Any material in this article should be considered general information, and not relied on as a formal investment recommendation.